Jesse Goodman

Jesse Goodman, MD, MPH is a Professor of Medicine and Attending Physician, Infectious Diseases, at Georgetown University, where he directs the Center on Medical Product Access, Safety, and Stewardship (COMPASS). At COMPASS Dr. Gooldman is addressing unmet public health needs with an emphasis on antimicrobial resistance and stewardship. Until February 2014 he served as the Chief Scientist of the US Food and Drug Administration (FDA), a position he assumed in 2009 along with Deputy Commissioner for Science and Public Health (2009-2012). From 2003 to 2009, he was Director of FDA’s Center for Biologics Evaluation and Research (CBER), overseeing activities critical to the U.S. and global preparedness and the development, evaluation, safety, quality, and availability of blood, vaccines, gene and cell therapies, and other biologics. As Senior Advisor to the FDA Commissioner from 1998-2000, he initiated and, with CDC and NIH colleagues, co-chaired the United States Task Force on Antimicrobial Resistance which produced the nation’s first Public Health Action Plan to Combat Antimicrobial Resistance.